NSC |
Compound |
Enrichment |
Correlation |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.0114553853234977 |
0.20340084 |
NSC 728512 |
1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine |
0.0114553853234977 |
0.12294562 |
NSC 734278 |
Null |
0.0114553853234977 |
0.055679219 |
NSC 745957 |
2-Benzylthio-4-chloro-N-[imino(3,4,5-trimethylpyrazol-1-yl)methyl]-5-methylbenzenesulfonamide |
0.0114553853234977 |
-0.025767352 |
NSC 747292 |
Null |
0.0114553853234977 |
0.062410351 |
NSC 755417 |
Null |
0.0114553853234977 |
0.16162891 |
NSC 123491 |
L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) |
0.0126882509540132 |
0.2353242 |
NSC 294530 |
Null |
0.0126882509540132 |
-0.12569131 |
NSC 5355 |
Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-, sulfate (2:1) (9CI) |
0.0126882509540132 |
0.23357778 |
NSC 59620 |
(4a,6a,9-trimethyl-6,7-dioxo-2,3,4,4b,5,6b,10,10a,11,11a,11b,12,13,13a-tetradecahydro-1H-indeno[2,1-a]phenanthren-2-yl) acetate |
0.0126882509540132 |
0.075036603 |